Edgewise Therapeutics Inc (EWTX) returns
Edgewise Therapeutics returns over 5 years
$1,000 invested in Edgewise Therapeutics five years ago was worth $2,358 at the close on October 30, 2026, with dividends reinvested: an average return of 18.7% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -4.2% | — | $958.13 | -0.9% |
| 3 months | -5.4% | — | $946.01 | +2.1% |
| Year to date | +56.8% | — | $1,568 | +11.7% |
| 1 year | +108.4% | — | $2,084 | +12.4% |
| 3 years | +469.5% | +78.6% | $5,695 | +88.5% |
| 5 years | +135.8% | +18.7% | $2,358 | +76.0% |
Edgewise Therapeutics return by calendar year
| Year | EWTX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +56.8% | +11.7% | +45.1% |
| 2025 | -7.1% | +17.7% | -24.8% |
| 2024 | +144.1% | +24.9% | +119.2% |
| 2023 | +22.4% | +26.2% | -3.8% |
| 2022 | -41.5% | -18.2% | -23.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Edgewise Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.